• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

This Week In FDA History - June 8, 1966

Phto of the FDA's first eight science advisors (clockwise from top left)

The FDA's first eight science advisors (clockwise from top left): Dr. Herman Szymanski, Buffalo District; Dr. Frederick R. Jensen, San Francisco District; Dr. Stanley Bruckenstein, Minneapolis District; Dr. Robert L. Pecsok, Los Angeles District; Dr. Paul Urone, Denver District; Dr. Robert Ginell, New York District; Dr. Clifton E. Meloan, Kansas City District; and Dr. Donald G. Davis, New Orleans District.
June 8, 1966:
Eight chemistry professors joined the FDA as science advisors, one assigned to each of the agency's districts. The appointments were part of a program to improve contacts between FDA field scientists and their academic counterparts. The chemists initiated programs to stimulate career development among the FDA's field personnel.

FDA in 2006

The Office of Regulatory Affairs (ORA) is the lead office for all of the FDA's field activities. ORA duties and functions include overseeing industry compliance with FDA regulations, coordinating legal action against violators of food and drug law, coordinating cooperative programs with state and local agencies, and directing the agency's emergency preparedness and civil defense programs. ORA also oversees regulatory agreements and memoranda of understanding between FDA and foreign countries. One ORA component, the Office of Criminal Investigations (OCI), directs criminal investigation activities in coordination with other FDA offices and other federal, state, and local law enforcement agencies. OCI develops training programs for criminal investigators and related personnel.